The correlation between skin tests and emetic responses in unsensitized monkeys was used to elucidate the cellular site of action of staphylococcal enterotoxin B (SEB). Evidence is presented that SEB administered intradermally provoked immediate-type skin reactions associated with mild degranulation of cutaneous mast cells. The cytoplasma showed signs of synthetic and metabolic activity, with formation of vesicles and increased prominence of mitochondria. Carboxymethylation of histidine residues of SEB altered the molecule (cSEB) from more alkaline components to more acidic species with increased microheterogeneity. This modification caused a loss in toxicity and completely abrogated the skin-sensitizing activity without changing the immunological specificity. cSEB, however, could compete with SEB for binding sites on the target cell surface. Previously, compound 48/80-treated skin sites behaved refractively to challenge with SEB, indicating that mediators from cutaneous mast cells are required for SEB-induced skin reactions. Skin reactions as well as emetic responses challenged with SEB were completely inhibited by H2 receptor antagonists and calcium channel blockers but not by HI antihistamine or competitive antagonists of serotonin. This new approach provides a model for investigating the mechanisms of SEB action.
Staphylococcal enterotoxin (SE), consisting of a single polypeptide chain, is responsible for the most prevalent type of foodborne debilating enteric intoxication in humans.
Administration of SE to monkeys or human volunteers produces emesis and diarrhea, the classic symptoms of food poisoning (1) , whereas laboratory animals show little if any clinical effect to peroral challenge with SEB. There are sequential morphologic (11) and ultrastructural (16) alterations associated with the oral administration of SE, and it has been suggested that the toxin-induced vomiting response follows stimulation of local neural receptors in the gastrointestinal tract (4) .
Although considerable efforts have been expended on attempts to clarify the pathogenesis of enterotoxemia, the target cells and subcellular structures involved in the intestinal site of SEB action still remain obscure.
In this report a new in vivo model is described for studies of SEB function by the direct skin test in Cynomolgus monkeys. A series of experiments provide evidence that SEB causes immediate-type skin reactions by degranulation of cutaneous mast cells. By using pharmacological agents, it could be established that the SEB-induced cutaneous hypersensitivity reaction and most notably the enteric intoxication as well are completely inhibited by H2 competitive antagonists of histamine and by calcium channel blockers. Therefore, the skin reactivity of SEB in monkeys may be a valuable tool for studies of the biologic function of the toxin and H2 receptor antagonists, and calcium channel blockers may prove to be a very useful prophylaxis or treatment of enteritic intoxications after challenge with SEB.
al. (5) . Carboxymethylation of SEB (cSEB) was effected by the method of Harris and Hill (7) by mixing 0.4 M bromoacetic acid (adjusted to pH 7.0 with 5 N NaOH) with an equal volume of 0.6% SEB in 0.5 M potassium phosphate buffer (pH 7.0). The solutions were incubated in the dark at room temperature for 7 days. At the end of the reaction period, the solution was dialyzed at 4°C against several changes of distilled water, and the protein concentration was determined by UV absorbance with absorbancy values of A1 m = 14.4 at 277 nm (19) . Amino acid analysis was performed on a Chromakon 500 analyzer (Kontron, Munich, Federal Republic of Germany) after hydrolysis in 6 N HCI (Ultrapur; Merck) for 24 h at 110°C. The integration constants for carboxymethylated derivatives of histidine used were described previously (3) .
Immunization. For primary immunization, BALB/c mice and LEW rats were injected intraperitoneally with SEB (1 and 10 jLg, respectively) mixed with 4 mg of Alu gel S in a total volume of 0.5 ml of phosphate-buffered saline (PBS). After 28-day intervals all animals were pretreated intraperitoneally with 175 mg of cyclophosphamide per kg, secondarily challenged with SEB 2 days later, and bled sequentially for determination of immunoglobulin E (IgE) anti-SEB antibody.
Strain 13 guinea pigs were primed intraperitoneally with 10 jg of SEB adsorbed on 4 mg of Alu gel S in a total volume of 1.0 ml and challenged three times at 30-day intervals with the same dose. All guinea pigs were pretreated intraperitoneally with 100 mg of cyclophosphamide per kg 2 days before each antigenic exposure.
Passive cutaneous anaphylaxis (PCA). Mouse and rat IgE antibodies were titrated in the dorsal skin of female BS rats that were sensitized intradermally with 0.1 ml of antiserum serially diluted twofold in PBS supplemented with 0.03% bovine serum albumin. After 72 h they were challenged intravenously with 1 ml of PBS containing 200 jig of SEB and 1% Evans blue. The titer was expressed as a reciprocal of serum dilutions yielding 5-mm-diameter reactions.
Guinea pig antisera at appropriate dilutions were injected intradermally into the dorsal skin surface of the homologous strain. After sensitization periods of 72 h, the animals were challenged by intravenous injection of 200 jig of SEB in 1 ml of PBS containing 1% Evans blue. The resulting blueing reactions were read 30 min after challenge and recorded as a reciprocal of the highest dilution giving a threshold (5- 
In another series of experiments, monkeys were passively sensitized by intradermal injection of 0.1 ml of serial dilutions of rat IgE anti-SEB antibodies into the ventral skin surface. After 72 h the monkeys received 2 ml of 1% Evans blue intravenously and were challenged with 0.05-ml portions of SEB or cSEB (40 jig/ml) into The effect of diphenhydramine, cimetidine, methysergide, and diltiazem on the response to intradermal SEB in highly sensitized BALB/c mice was tested by intravenous administration of the drugs 15 min prior to challenge at the indicated dosage. In additional experiments the response to SEB was examined after intragastric intubation of doxantrazole 60 min before challenge.
Biopsy and processing of tissue for ultrastructural examination. Surgically excised skin specimens were obtained 15 min after skin tests under anesthesia. The skin sample was prepared for light and electron microscopy as described previously (12) . Briefly, semithin sections (0.5 to 1 jim) for light microscopy and thin sections (50 nm) for electron microscopy were cut from tissues embedded by the method of Spurr (22) 
RESULTS
Carboxymethylation of SEB. Previous studies had established that carboxymethylation of SEA caused a significant reduction in toxicity without changing the immunological specificity of the molecule (23) . Obviously, the reaction of bromoacetic acid with SEB was similar to that of SEA and specific for histidine residues under the conditions used. Of the six histidine residues present in our SEB preparation (5), 4.96 residues were derivatized to 3-monocarboxymethylhistidine and 1.05 residues were derivatized to 1,3-carboxymethylhistidine. There was no histidine residue refractive to carboxymethylation. This chemical modification of SEB caused a conversion from alkaline components to more acidic species and an increase in microheterogeneity (Fig.1) .
To compare the emetic efficiency of SEB and cSEB, the toxin was administered to Cynomolgus monkeys by gastric tube. Whereas the emetic 100% effective dose of SEB was found to be less than 5 jig/kg, cSEB consistently failed to evoke emetic responses even when five times the effective dose of SEB was used.
Skin reactions elicited by SEB and cSEB. In an attempt to delineate the target cells possibly involved in the site of toxin action, the effectiveness of SEB in eliciting skin reactions in highly sensitized guinea pigs and BALB/c mice as well as in unsensitized Cynomolgus monkeys was compared.
An intense and persistent IgE anti-SEB response was established in BALB/c mice (PCA titer, 2048) and strain 13 guinea pigs (PCA titer, 8192) pretreated with cyclophosphamide, followed by two to four sensitizing doses of 2 to 10 ,ug of SEB. From the experimental details and the results given in Table 1 , it is apparent that SEB was effective in eliciting immediate-type skin reactions in sensitized BALB/c mice and guinea pigs in a range of 10-9 to 10-12 M, and the sensitivity of the assay system correlated strongly with the serum IgE antibody level.
SEB, modified by carboxymethylation (cSEB), resulting in a complete loss in the toxic activity, however, showed only a slight reduction in its efficiency to elicit skin reactions in sensitized animals. In contrast, SEB consistently failed to provoke skin reactions in unsensitized guinea pigs and BALB/c mice.
The most notable feature, however, is the fact that comparatively SEB behaved effectively in promoting immediatetype skin reactions at equimolar toxin solutions in unsensitized monkeys proved to be free of any anti-SEB antibody. Chemically modified cSEB, however, was incapable of evoking skin reactions in unsensitized monkeys when tested at doses up to 10-4 M.
Effect of compound 48/80 and cSEB on SEB-induced skin reactions. To establish whether the hypersensitivity-like reaction in monkeys was due to a direct effect of SEB on cutaneous mast cells, the observation was utilized that mast cells initially exposed to a mast cell-degranulating agent become unresponsive to a subsequent exposure to a second challenging agent (17) . Skin SEB (Fig. 2) . From the results, it is also apparent that exposure of sensitized skin sites to an equimolar solution of cSEB resulted in only a slight reduction of the skin reaction. Immediate-type reactions in sensitized skin sites, however, were completely inhibited by pretreatment with compound 48/80 24 h before SEB challenge. Analogously unsensitized skin sites initially exposed to compound 48/80 became totally unresponsive to a subsequent exposure to the same activator as well as to SEB challenge. Further, there is evidence that skin responses to histamine (1 jig) were not significantly influenced by previous compound 48/80 treatment as compared with responses at control sites. Unsensitized skin sites pretreated with buffer, however, were fully capable of a subsequent response to compound 48/80. To determine whether cSEB, which is incapable of evoking reactions in unsensitized skin sites, and SEB were interacting with the same putative receptor on the target cell, inhibition experiments were performed. It is apparent from the data (Fig. 2) that the immediate skin reaction following challenge with SEB was completely inhibited in the presence of cSEB, when used at a 5-times molar excess. There was no significant inhibition noted, however, when the concentrations of SEB and inhibitor were equimolar.
Effect of drugs on skin reaction and emetic response after SEB challenge. The ability of SEB to elicit an immediate-type skin reaction in unsensitized monkeys was more closely examined in an attempt to establish the release of vasoactive amines from mast cells by pharmacological treatment.
The data (Fig. 3) show clearly that the immediate skin response in highly sensitized BALB/c mice upon challenge with SEB was totally abrogated by treatment with the serotonin antagonist methysergide at a dose of 30 xug/kg. In contrast, diphenhydramine and cimetidine, the Hi-and H2-competitive antagonists of histamine, had no significant effect on the skin response, when compared with the control value. However, diltiazem, a calcium channel blocker, at a dose of 0.3 mg/kg completely prevented SEB-induced skin reactions in sensitized mice. The intragastric administration of doxantrazole at 3 mg/kg abrogated the skin response as well.
In unsensitized monkeys, diphenhydramine caused a substantial inhibition of the immediate skin reaction but failed to have any influence on the emetic response following challenge with SEB by gastric tube.
Pretreatment with cimetidine, a selective blocker of the H2 receptor, however, completely and consistently prevented emesis and diarrhea.
Methysergide at a dose of 30 kg/kg, giving optimal therapeutic levels in human plasma (15), did not have any inhibitory effect when administered 15 min prior to SEB challenge by gastric tube. The immediate skin reaction as well as the emetic response following exposure to SEB, however, was totally abrogated by the calcium channel blocker diltiazem (0.3 mg/kg) and doxantrazole (3 mg/kg) administered by intragastric intubation.
Ultrastructural changes in skin reactions after SEB challenge. The cytoplasm of mast cells in control biopsies are packed with typical electron-dense granules of uniform size but variable shape (Fig. 4A) . Rarely, a few scattered granules have lost the bulk of their normally dense contents. Mast cells from the skin reaction challenged with SEB show granule alteration including limited fusion of granule membranes, some loss of electron-dense particle content, and limited fusion of adjacent granules (Fig. 4B) 4C). The cytoplasm contains numerous mitochondria and vesicles partly associated with the granules. Extrusion of intact mast cells through the plasma membrane was not observed but may have been a relatively rare and rapid event, difficult to capture in static micrographs. This is opposed to extensive degranulation of mast cells exposed by compound 48/80. There is an extensive loss of granule density, and the changed granules were situated in large membrane-bounded labyrinthine cavities (Fig. 4E) . In many places, however, the cavities appeared as closed vacuoles. The nuclei are pycnotic, and the cell membranes cannot be identified.
Mast cells in skin sites challenged with cSEB ( Fig. 4D) , however, had no distinctly different morphology from those of control skin (Fig. 4A) .
DISCUSSION
In the present study we attempted to elucidate the pathological mechanisms involved in the site of action of SEB. The first approach was based on the finding that carboxymethylation of enterotoxin A resulted in a loss of toxicity in the absence of a gross conformational change (23) . Analogous treatment of SEB with bromoacetate at pH 7.0 for 7 days modified all histidine residues and abrogated the toxicity completely. After carboxymethylation of SEB, however, there was a conversion from more alkaline components to more acidic species with increased microheterogeneity of the molecule.
Further, the results clearly show that cSEB is almost equally effective as the native molecule in eliciting immediate skin reactions in guinea pigs and BALB/c mice highly sensitized with SEB-specific IgE antibody. This is also true for monkeys whose skin sites were prepared by injection with IgE anti-SEB antibody. Therefore, it is reasonable to conclude that carboxymethylation of SEB results only in a slight reduction in the ability of the derivative to react with Ig1 antibodies. This finding agrees well with existing data, where carboxymethylated enterotoxin A showed no loss in the ability to precipitate with antibody to the native toxin (23) . Of particular importance was the finding that low concentrations (10-' M) of SEB were highly efficient in promoting immediate-type skin reactions in unsensitized monkeys proved to be free of any anti-SEB antibody, whereas cSEB consistently failed to do so even when injected at concentrations of up to 10-4 M. These observations lead us to favor the hypothesis that triggering of mast cells by a nonimmunological stimulus depends on the requirement for positive charge of the active peptide (2) . The basis for the loss in skin sensitizing activity by carboxymethylation of SEB, may involve modified amino acid residues located within or near a (toxic) site that binds to target cells.
However, SEB was completely ineffective in inducing comparable reactions in skin sites of unsensitized guinea pigs or BALB/c mice. Since the ability of SEB to promote immediate skin reactions and enteritic intoxication is obviously restricted to primates, it might be assumed that molecular regions on SEB, so far not clearly defined, show a high degree of specificity, in so far as the reaction with a putative receptor on the target cell is concerned. To obtain more direct evidence in support of a mast cell triggering process in unsensitized monkeys following SEB challenge, one approach was based on mast cell desensitization. Thus, refractory states have been reported against immediate-type reactions, supporting the occurrence of specific desensitization in addition to mediator depletion (6) . The present results provide compelling evidence that treatment of presensitized or unsensitized skin sites with compound 48/80 completely abolished the immediate response to a subsequent challenge with SEB, indicating that mediators of cutaneous mast cells are required. It was ascertained that vascular reactivity was not significantly reduced by comparing the response to histamine at a pretreated site versus a control site. This argues against the possibility that a histamine liberator- There is evidence that SE are potent mitogens activating T-lymphocytes to secrete gamma interferon (13 The current study has further demonstrated that skin reactions in sensitized BALB/c mice and unsensitized monkeys following challenge with SEB differed with regard to the vasoactive amines released. Thus, the serotonin antagonist methysergide totally blocked the immediate-type reaction in sensitized mice, whereas Hi and H2 histamine receptor antagonists failed to inhibit the skin response significantly. In this context, however, it should be considered that the peripheral vessels of mice are rather insensitive to histamine and quite sensitive to serotonin (20) . These data could be suggestive of a deficiency of functional histamine receptors in mice accounting for the inefficiency of histamine antagonists. In addition, pretreatment with the calcium channel blocker diltiazem totally abrogated skin reactions in sensitized BALB/c mice after SEB challenge, most probably by preventing the transporting mechanisms or channel conductance for calcium ions (14) . Based on these studies, the use of pharmacologic agents should also provide a more complete assessment of the skin reactivity upon challenge Although SEB-induced immediate skin response is consistent with mast cell activation, so far there is no definite proof that histamine is the principle mediator of these reactions. Rather, the lack of ability of H2 receptor antagonists alone to inhibit the skin response to histamine or the PCA reactions to antigen in monkeys (8) argues against the predominance of histamine, and the possibility must be considered that mediators other than histamine are important in the pathogenesis of SEB-induced skin reaction. However, the results of Hutchroft et al. (8) must be interpreted cautiously; it is apparent from our observation that the H2 antagonist cimetidine at a dose of 1 mg/kg clearly inhibited the wheal-andflare response to intradermal histamine in baboons (P. H. Scheuber, unpublished data). In contrast, the finding that H2 antihistamine completely prevented the emetic response as well upon SEB challenge was surprising. The mechanism accounting for this observation is not defined by the present data; however, there is some indication that atypical (mucosal) mast cells may also be involved in the intestinal site of action of SEB (P. H. Scheuber, H. Rang, J. Golecki, and D. K. Hammer, manuscript in preparation). Further, the inhibitory effect of doxantrazole and the calcium channel blocker diltiazem on both the cutaneous reaction and the emetic response suggests that a predominant step in the sequence of biochemical events following SEB challenge is the role of calcium ions as a second messenger mediating the action of the ligand (9).
In conclusion, the association between skin test reactivity and emetic response following challenge with SEB is a new approach and may provide a model for investigation of the operative mechanism in enterotoxemia.
